GenPath Diagnostics

GenPath Diagnostics, established in 1997, operates as a specialized diagnostic laboratory service provider within the healthcare sector. As a division of BioReference Laboratories and a subsidiary of OPKO Health, the company offers comprehensive testing solutions designed to support healthcare professionals across various specialties. Its diverse test menu is specifically tailored for oncologists, pathologists, urologists, hematologists, maternal fetal medicine specialists, and OB/GYNs, underscoring a commitment to precision diagnostics. GenPath Diagnostics leverages scientific expertise and medical knowledge to deliver innovative services that aim to enhance patient care through accurate and reliable diagnostic testing. The company serves both healthcare organizations and individual patients, reinforcing its role in advancing healthcare quality.

The laboratory's offerings extend beyond conventional testing, focusing on a broad portfolio that includes molecular diagnostics, oncology testing, and specialized panels. This comprehensive approach aids physicians in patient monitoring and treatment guidance. With a revenue of $367.0M and an employee range of 1,000-5,000 individuals across 4 locations, GenPath Diagnostics demonstrates significant operational scale. The organization is dedicated to providing state-of-the-art diagnostic services, combining advanced technology with clinical insights to meet the evolving needs of the medical community. To learn more about the professionals driving these advancements, consider Meet GenPath Diagnostics's team.

GenPath Diagnostics positions itself as a key player in the medical testing and clinical laboratories industry, competing with entities like Aurora Diagnostics and DCH Health System. Its strategic focus on specialized diagnostics, particularly in oncology and women's health, allows it to cater to specific clinical requirements. The company's commitment to pricing transparency and deliveringView more...